u/ignacio_roos

Total transit includes a clearance stage that is not under the carrier’s control. Separating clearance time from carrier time is the first step in diagnosing any delay.

Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.

nothing in this board is legal advice

Research-use-only labelling is a description of intended use, not a customs classification.

Adding the standing caveat — nothing here is legal advice and this one genuinely warrants somebody qualified.

Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.

the rules differ between neighbouring countries and change by year

Scotland, Wales and Northern Ireland have their own arrangements. An answer that begins with "in England" should say so, and most of the confusion here comes from answers that do not.

Switched pharmacies mid-titration and had to restart the ladder because the concentrations did not line up.

the price difference between pharmacies this month is genuinely large

Where a supplier holds regional stock, the shipment is domestic and there is no import event at all. That is the structural fix rather than a workaround.

Not convinced — the US threads are a different system entirely and importing their advice here does real harm.

Agreed.

Agreed — and keeping the letters with dates is what makes any later challenge possible.

keep the paperwork, including the boring parts

Yes — the consultation that asks nothing tells you what kind of service it is.

NHS pathway or private prescription?

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

Which nation, and which ICB if you are in England?

That is the first-month offer price, not the ongoing monthly cost. The tracker records the second one.

Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.

Same. Net peptide content is where the difference between the label and the vial actually shows up.

catalogue depth is not the same as catalogue quality

Asked somebody qualified locally rather than relying on this board. Best forty minutes I have spent on the topic.

private prescription pricing moves monthly and the pharmacy is most of the spread

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.

Why the monthly pricing tracker works, and the rule that makes it work.

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

specialist service, not GP, for tier 3 in most of England

Yes — four nations, four pathways, and threads that ignore that give people the wrong answer confidently.

Yes — a hold and a seizure are different events with different processes, and this board mixes them weekly.

What storage conditions did they specify?

Yes. Nothing in this catalogue is approved for human use and the board should keep saying so.

the Irish scheme cap is the single most useful fact in this board